Vikraman Subhramani
Papers
1
Total Citations
2
H-Index
1
About
Vikraman Subhramani is a radiation oncologist whose research centers on stereotactic body radiotherapy (SBRT) and CyberKnife robotic radiosurgery, particularly for treating metastatic disease. His most notable contribution is a pioneering study on CyberKnife fractionated radiotherapy for adrenal metastases, published in 2014 from a multispecialty Indian cancer care center. This work was among the early reports demonstrating that SBRT could achieve durable disease control—not merely pain palliation—for adrenal metastases originating from lung, breast, and kidney malignancies. The study helped shift clinical perspectives on radiotherapy's role in oligometastatic disease, showing that precise, high-dose radiation could be safely delivered to the adrenal gland. While his citation count for this specific paper is modest at 2, its significance lies in its foundational nature for a then-emerging treatment paradigm in India. Subhramani's work contributes to the broader evidence base supporting SBRT as a non-invasive alternative to surgery for selected metastatic sites, potentially improving outcomes for patients with limited metastatic burden. His research exemplifies the translation of advanced radiation technology into practical, accessible cancer care.
Research Focus
Key Achievements
Top Papers
- 1